| 1 | european society of gynaecological | | | | | | | 5 | 0.34% |
| 2 | society of gynaecological oncology | | | | | | | 5 | 0.34% |
| 3 | 2024 barcelona spain over | | | | | | | 2 | 0.14% |
| 4 | 710 2024 barcelona spain | | | | | | | 2 | 0.14% |
| 5 | march 710 2024 barcelona | | | | | | | 2 | 0.14% |
| 6 | and research of gynaecologic | | | | | | | 2 | 0.14% |
| 7 | treatment care and research | | | | | | | 2 | 0.14% |
| 8 | sharing realworld clinical data | | | | | | | 2 | 0.14% |
| 9 | of gynaecological oncology esgo | | | | | | | 2 | 0.14% |
| 10 | care and research of | | | | | | | 2 | 0.14% |
| 11 | | | | | | | | 2 | 0.14% |
| 12 | for more information view | | | | | | | 2 | 0.14% |
| 13 | esgoeuropean society of gynaecological | | | | | | | 2 | 0.14% |
| 14 | esgo centre candidacy programme | | | | | | | 2 | 0.14% |
| 15 | calculators watch the video | | | | | | | 1 | 0.07% |
| 16 | explore calculators watch the | | | | | | | 1 | 0.07% |
| 17 | patients with earlystage disease | | | | | | | 1 | 0.07% |
| 18 | to patients with earlystage | | | | | | | 1 | 0.07% |
| 19 | applicable to patients with | | | | | | | 1 | 0.07% |
| 20 | a model applicable to | | | | | | | 1 | 0.07% |
| 21 | model applicable to patients | | | | | | | 1 | 0.07% |
| 22 | centre candidacy programme esgo | | | | | | | 1 | 0.07% |
| 23 | on a model applicable | | | | | | | 1 | 0.07% |
| 24 | based on a model | | | | | | | 1 | 0.07% |
| 25 | and postrecurrence survival prediction | | | | | | | 1 | 0.07% |
| 26 | candidacy programme esgo has | | | | | | | 1 | 0.07% |
| 27 | watch the video with | | | | | | | 1 | 0.07% |
| 28 | video with david cibula | | | | | | | 1 | 0.07% |
| 29 | the video with david | | | | | | | 1 | 0.07% |
| 30 | manner calculators promo esgo | | | | | | | 1 | 0.07% |
| 31 | with david cibula and | | | | | | | 1 | 0.07% |
| 32 | david cibula and daniela | | | | | | | 1 | 0.07% |
| 33 | fischerova introducing the new | | | | | | | 1 | 0.07% |
| 34 | introducing the new calculators | | | | | | | 1 | 0.07% |
| 35 | risk and postrecurrence survival | | | | | | | 1 | 0.07% |
| 36 | the new calculators in | | | | | | | 1 | 0.07% |
| 37 | new calculators in a | | | | | | | 1 | 0.07% |
| 38 | calculators in a simple | | | | | | | 1 | 0.07% |
| 39 | promo esgo centre candidacy | | | | | | | 1 | 0.07% |
| 40 | calculators promo esgo centre | | | | | | | 1 | 0.07% |